Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03421223 · ClinicalTrials.gov registry record
Digital Signals in Chronic Pain (DiSCover Project)
A clinical trial, sponsored by Evidation Health.
- Completed
- Registry status
- 10,161
- Enrollment target
NCT03421223: Completed study, sponsored by Evidation Health.
NCT03421223 is a clinical trial that has completed, run by Evidation Health. The registered enrollment target is 10,161 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03421223 has completed, sponsored by Evidation Health.
- COMPLETED
- Registry status
- 10,161 participants
- Enrollment target
Study Summary
The DiSCover Project is a 1-year longitudinal case-control observational study. In this study, the investigators plan to collect different types of data including self-reported health outcomes and quality of life data, behavioral data from activity trackers and health and fitness apps, data from lab tests, genetic data, and environmental data. One of the goals of this study is to develop digital biomarkers for chronic pain severity, flare ups and quality of life.
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,161 participants |
| Start Date | 2018-01-08 |
| Est. Completion | 2020-01-15 |
What the finished NCT03421223 record still lists
NCT03421223 is an observational study that tracks outcomes without assigning an intervention. Its 10,161 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT03421223 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03421223 about?
NCT03421223 is a clinical study titled "Digital Signals in Chronic Pain (DiSCover Project)". The DiSCover Project is a 1-year longitudinal case-control observational study. In this study, the investigators plan to collect different types of data including self-reported health outcomes and quality of life data, behavioral data from activity trackers and health and fitness apps, data from lab...
What is the current status of trial NCT03421223?
This trial is currently completed. The enrollment target is 10,161 participants. The study started on 2018-01-08. Estimated completion is 2020-01-15.
What interventions are being tested in trial NCT03421223?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT03421223?
This trial is sponsored by Evidation Health, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04332783 · 10,120 participants · NA
Isolating and Mitigating Sequentially Dependent Perceptual Errors in Clinical Visual Search
- NCT00160771 · 10,000 participants
Biomechanics/Motion Analysis Laboratory Data Bank
- NCT00896935 · 10,000 participants
Arizona Cancer Center Biospecimen Repository
- NCT00898235 · 10,000 participants
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI